PGP and cancer: In previous work from our group, we used computational methods to develop structural models of one of these pumps, P-gp,[12, 13] which were used in ultrahigh throughput in silico screening approaches to identify[14] and characterize [15, 16] drug-like compounds that inhibited P-gp and reversed multidrug resistance in several cancer cells in culture.